Sunday, December 17, 2017 12:17:53 PM
Lots of companies fight for NIH funding, maybe you point me to another potentially 100% safe, effective depression drug the NIH funded over the last decade. LOL
I haven't seen any postings from you on SAGE that they don't have any sales, I am surprised you have not posted that the phase 2 depression data that caused that NO SALES company to jump $75.00 in a day was a scam pump and dump. Do you also think that Allergan is throwing 2 billion dollars away by buying a similar acting drug to AV 101 that can only be administered by intravenous.
Seth was very fortunate to be able to participate in this funding and get 320,000 warrants and a kicker...
GAME SET MATCH TAUG
and no, I am not a consultant for VTGN and do not have any contracts as such. but as I repeatedly told you we loved the stock at 3.5 and love it even more down here...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM